Literature DB >> 7572543

[Anaphylaxis caused by royal jelly].

A Roger1, N Rubira, C Nogueiras, R Guspi, M Baltasar, A Cadahia.   

Abstract

Royal jelly is the food on which are fed and which causes them to develop into queen bees. It is claimed to have rejuvenating virtues for human beings. This report describes a 15-year-old atopic woman who presented, 15 minutes after the intake of royal jelly, local angioedema, generalised urticaria, dysphonia and bronchospasm. She was given antihistaminics and corticoesteroids and responded well. The ingested product contains royal jelly, lactose and potassium sorbate. No anaphylactic reactions to lactose and sorbates have been described previously. Prick test to common food allergens hymenoptera venoms and pollens were negative. RAST to meletin was also negative. Blood eosinophils were 600 and total IgE 465. Non-commercial prepared specific IgE to royal jelly was positive (0.8 KU/l). Prick by prick was positive to 1/10 dilution, being negative in controls (undiluted). No oral provocation test was performed due to the risk of anaphylaxis. No reported cases of royal jelly allergy were founded in a review of the medical literature. Concluding, it is the first described case of IgE anaphylactic reaction due to royal jelly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572543

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  3 in total

Review 1.  Review of the anticancer activities of bee products.

Authors:  Pongsathon Premratanachai; Chanpen Chanchao
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial.

Authors:  Mansour Siavash; Saeideh Shokri; Sepehr Haghighi; Mohammad Ali Shahtalebi; Ziba Farajzadehgan
Journal:  Int Wound J       Date:  2013-04-08       Impact factor: 3.315

3.  In Vitro and In Vivo Antioxidant and Anticancer Potentials of Royal Jelly for Dimethylhydrazine-Induced Colorectal Cancer in Wistar Rats.

Authors:  Maede Shakib Khoob; Seyed Mohammad Hosseini; Sohrab Kazemi
Journal:  Oxid Med Cell Longev       Date:  2022-07-21       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.